Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8749rdf:typepubmed:Citationlld:pubmed
pubmed-article:8749lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:8749lifeskim:mentionsumls-concept:C0002600lld:lifeskim
pubmed-article:8749lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:8749lifeskim:mentionsumls-concept:C0012030lld:lifeskim
pubmed-article:8749lifeskim:mentionsumls-concept:C0028454lld:lifeskim
pubmed-article:8749pubmed:issue562lld:pubmed
pubmed-article:8749pubmed:dateCreated1976-10-20lld:pubmed
pubmed-article:8749pubmed:abstractTextThe study undertook to compare the efficacy of dibenzepin and amitriptyline in the treatment of endogenous depression. The outcome of the study was that both drugs appear to be equally effective in the treatment of depression, but dibenzepin was more efficient in reducing associated anxiety. Both drugs are appropriate to the treatment of psychotic depression, and work equally rapid. There was also a tendency for dibenzepin to elicit less intense side effects.lld:pubmed
pubmed-article:8749pubmed:languageenglld:pubmed
pubmed-article:8749pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8749pubmed:citationSubsetIMlld:pubmed
pubmed-article:8749pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8749pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8749pubmed:statusMEDLINElld:pubmed
pubmed-article:8749pubmed:monthAprlld:pubmed
pubmed-article:8749pubmed:issn0028-8446lld:pubmed
pubmed-article:8749pubmed:authorpubmed-author:WilliamsH EHElld:pubmed
pubmed-article:8749pubmed:authorpubmed-author:CANTUWWlld:pubmed
pubmed-article:8749pubmed:authorpubmed-author:UngerH RHRlld:pubmed
pubmed-article:8749pubmed:authorpubmed-author:KnightR GRGlld:pubmed
pubmed-article:8749pubmed:issnTypePrintlld:pubmed
pubmed-article:8749pubmed:day28lld:pubmed
pubmed-article:8749pubmed:volume83lld:pubmed
pubmed-article:8749pubmed:ownerNLMlld:pubmed
pubmed-article:8749pubmed:authorsCompleteYlld:pubmed
pubmed-article:8749pubmed:pagination273-4lld:pubmed
pubmed-article:8749pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Hum...lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Dep...lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Fem...lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Mal...lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Mid...lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Cli...lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Ami...lld:pubmed
pubmed-article:8749pubmed:meshHeadingpubmed-meshheading:8749-Dib...lld:pubmed
pubmed-article:8749pubmed:year1976lld:pubmed
pubmed-article:8749pubmed:articleTitleA double blind study of the antidepressants dibenzepin (Noveril) and amitriptyline.lld:pubmed
pubmed-article:8749pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8749pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8749pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8749pubmed:publicationTypeControlled Clinical Triallld:pubmed